patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: NEWS THIS AM: PSTI ANNOUNCES 6-MONTH FOLLOW UP RESULTS

InPlay: Pluristem Therapeutics announces six-month follow-up results of its phase I critical limb ischemia clinical trials; phase I suggest co's placenta-derived cell therapy, PLX-PAD, is safe, improves quality of life, and is potentially eBriefing.com(Wed 7:17AM EDT)

Share
New Message
Please login to post a reply